Breaking News Instant updates and real-time market news.

BAC

Bank of America

$27.15

-0.6 (-2.16%)

, SNAP

Snap

$11.98

0.31 (2.66%)

07:35
05/31/19
05/31
07:35
05/31/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in Bank of America (BAC), Snap Inc. (SNAP), Centene (CNC), Uber (UBER), Beyond Meat (BYND), Dicks (DKS), Hertz (HTZ), Oasis Petroleum (OAS), Clovis (CLVS), and Ally Financial (ALLY).

BAC

Bank of America

$27.15

-0.6 (-2.16%)

SNAP

Snap

$11.98

0.31 (2.66%)

CNC

Centene

$56.99

0.75 (1.33%)

UBER

Uber

$39.76

-0.155 (-0.39%)

BYND

Beyond Meat

$98.28

1.15 (1.18%)

DKS

Dick's Sporting

$34.22

0.565 (1.68%)

HTZ

Hertz

$14.57

-0.62 (-4.08%)

OAS

Oasis Petroleum

$5.20

-0.04 (-0.76%)

CLVS

Clovis

$15.01

-0.85 (-5.36%)

ALLY

Ally Financial

$29.19

-0.05 (-0.17%)

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 06

    Jun

  • 06

    Jun

  • 11

    Jun

  • 12

    Jun

  • 14

    Jun

  • 24

    Jun

  • 17

    Jul

  • 23

    Jul

BAC Bank of America
$27.15

-0.6 (-2.16%)

04/30/19
04/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Hold from Buy at Stifel with analyst Scott Devitt saying Alphabet revenue growth in last night's Q1 results dropped below 20% for the first time since Q2 of 2015. 2. Bank of America (BAC) downgraded to Neutral from Overweight at Atlantic Equities. 3. Trade Desk (TTD) downgraded to Market Perform from Outperform at JMP Securities with analyst Ronald Josey saying he believes shares are currently fairly valued given the company's growth and opportunities in mobile and Connected TV. 4. ADP (ADP) downgraded to Market Perform from Outperform at Bernstein while Paychex (PAYX) was downgraded to Underperform from Market Perform. 5. Trex Company (TREX) downgraded to Neutral from Buy at B. Riley FBR with analyst Alex Rygiel citing near-term profit margin pressures. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/17/19
BMOC
04/17/19
NO CHANGE
Target $37
BMOC
Market Perform
Bank of America price target raised to $37 at BMO Capital after Q1 results
BMO Capital analyst James Fotheringham raised his price target on Bank of America (BAC) to $37 from $36 after its Q1 earnings beat that was driven by reduced costs and to reflect a roll out in his model by one quarter, but also lowered his FY19 EPS view by 4c to $3.05 due to lower than expected net interest income. The analyst is also keeping his Market Perform rating on the shares, stating that among the "U.S. big four banks", he prefers Citigroup (C).
04/17/19
04/17/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PayPal (PYPL) downgraded to Neutral from Buy at UBS with analyst Eric Wasserstrom saying his analysis of PayPal's core operations indicates "limited beat-and-raise potential" over the next two years. 2. GasLog Partners (GLOP) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Fotis Giannakoulis saying he believes the partnership's ability to accretively fund new dropdowns has become increasingly more challenging. 3. Bank of America (BAC) downgraded to Hold from Buy at Jefferies with analyst Kenneth Usdin saying he does not see enough upside to warrant a Buy rating. 4. Comerica (CMA) downgraded to Outperform from Strong Buy at Raymond James and to Hold from Buy at Jefferies. 5. Skyworks (SWKS) downgraded to Neutral from Outperform at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/30/19
ATLE
04/30/19
DOWNGRADE
ATLE
Neutral
Bank of America downgraded to Neutral from Overweight at Atlantic Equities
SNAP Snap
$11.98

0.31 (2.66%)

05/13/19
RBCM
05/13/19
INITIATION
Target $28
RBCM
Sector Perform
Pinterest initiated with a Sector Perform at RBC Capital
RBC Capital analyst Mark Mahaney initiated Pinterest with a Sector Perform rating and a price target of $28. The analyst is positive on the company's "very large market opportunity" in advertising and believes that it is benefiting from "powerful" secular tailwinds, boasting a monthly active user, or MAU, count above that of Twitter (TWTR) and growing the MAUs faster than Snap (SNAP). Despite his belief than Pinterest can sustain a double-digit growth rate in MAUs and Average Revenue Per User until 2021, Mahaney sees its stock as "reasonably valued" after a 50% run-up from its IPO price.
05/29/19
PIVT
05/29/19
INITIATION
Target $13.25
PIVT
Hold
Snap initiated with a Hold at Pivotal Research
Pivotal Research analyst Michael Levine started Snap with a Hold rating and $13.25 price target. The analyst is "highly encouraged" by the company's progress over the last several quarters. However, he needs to be convinced that Snap has strength outside of several advertising verticals.
05/29/19
CHRS
05/29/19
INITIATION
Target $12
CHRS
Hold
Snap initiated with a Hold at China Renaissance
China Renaissance analyst Ella Ji initiated Snap with a Hold and $12 price target saying valuation reflects many positives.
05/29/19
05/29/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), Facebook (FB), and Twitter (TWTR) were initiated with a Buy at Pivotal Research, while Alphabet (GOOG, GOOGL), Pinterest (PINS), and Snap (SNAP) were initiated with a Hold. 2. Anchiano Therapeutics (ANCN) initiated with an Outperform at Baird. 3. Slack Technologies (WORK) initiated with a Neutral at DA Davidson. 4. National Vision (EYE) initiated with a Buy at Berenberg. 5. IMV Inc. (IMV) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
CNC Centene
$56.99

0.75 (1.33%)

05/10/19
SBSH
05/10/19
UPGRADE
SBSH
Buy
Centene upgraded to Buy from Neutral at Citi
Citi analyst Ralph Giacobbe upgraded Centene to Buy from Neutral.
05/16/19
COWN
05/16/19
NO CHANGE
COWN
Move lower in managed care stocks appears overdone, says Cowen
Cowen analyst Charles Rhyee lowered his target multiple for the managed care group slightly from recent historical levels, but said he believes the recent weakness in the space on concerns around "Medicare for All," the rebate rule and the Texas ACA decision appears overdone. The discount for managed care stocks relative to the broader market has risen to a multi-year high, but he argues that underlying market fundamentals are stronger than in the pre-ACA era and Rhyee contends that there is "still plenty of growth left" in the managed care space, particularly in government-sponsored business. Stocks in the group include Anthem (ANTM), Cigna (CI), Centene (CNC), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH) and WellCare (WCG).
05/10/19
05/10/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. 3D Systems (DDD) upgraded to Neutral from Underweight at JPMorgan with analyst Paul Coster noting the stock is down 25% this week after posting "lackluster" Q1 results. 2. Jones Lang LaSalle (JLL) upgraded to Buy from Neutral at Goldman Sachs with analyst Andrew Rosivach saying the company's earnings declined in Q1 due to tough comps, but this should reverse quickly. 3. Ford (F) upgraded to Buy from Neutral at BofA/Merrill with analyst John Murphy stating the company's earnings are starting to hit a "sustainable inflection" due to favorable product cadence in the North America market and its restructuring efforts. 4. Whirlpool (WHR) upgraded to Buy from Neutral at Longbow with analyst David MacGregor seeing earnings upside from better than expected North American margin performance, a "gradually improving" environment in the EMEA and a favorable cyclical turn in Latin America. 5. Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) upgraded to Buy from Neutral at Citi with analyst Ralph Giacobbe the magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/10/19
05/10/19
UPGRADE

Citi upgrades Anthem, Centene, UnitedHealth to Buy after 'extreme' selloff
Citi analyst Ralph Giacobbe upgraded Anthem (ANTM), Centene (CNC), and UnitedHealth (UNH) to Buy from Neutral while maintaining Buy ratings on Cigna (CI) and Humana (HUM). The magnitude of the selloff in managed care stocks on fears of Medicare for All has been "extreme and overdone," Giacobbe tells investors in a research note. The analyst sees favorable risk/rewards in the sector and does not subscribe to the view of a continued "overhang" and "uncertainty." Instead, Giacobbe expects a share recovery as "more realistic views prevail and investors become more numb to the low-likelihood headlines and political rhetoric of single payor."
UBER Uber
$39.76

-0.155 (-0.39%)

05/31/19
WEDB
05/31/19
NO CHANGE
Target $65
WEDB
Outperform
Uber's Q1 'an important step,' says Wedbush
Wedbush analyst Ygal Arounian reiterated an Outperform rating and $65 price target on Uber following the comany's Q1 results, saying the report was an "important step" for the company as investors needed a bridge between near-term headwinds and the long-term vision working. Additionally, Arounian says he feels that the results addressed many concerns investors had been seeking clarity on, despite not giving revenue or EBITDA guidance for the full year.
05/31/19
ATLE
05/31/19
UPGRADE
Target $52
ATLE
Overweight
Atlantic upgrades Uber on 'increasingly benign' competitive environment
Atlantic Equities analyst James Cordwell upgraded Uber Technologies to Overweight from Neutral while lowering his price target for the shares to $52 from $55. The stock closed yesterday down 14c to $39.80. The ridehailing competitive environment is becoming "increasingly benign" while Uber shares have become more attractively valued, Cordwell tells investors in a research note. The analyst expects a better competitive environment to drive accelerating revenue growth and moderating segment losses across fiscal 2019. Further, a new Uber Eats fee structure should augment the company's food delivery economics while enabling "rapid" bookings growth, Cordwell tells investors in a research note.
05/31/19
JPMS
05/31/19
NO CHANGE
Target $86
JPMS
Overweight
JPMorgan says buy Lyft as shares offer 50% potential upside
After hosting investor meetings with management, JPMorgan analyst Doug Anmuth recommends buying shares of Lyft (LYFT) on the "increasingly rational" ridesharing industry as well as the company's improving profitability. Management's overall tone was very confident around the easing of the competitive environment in U.S. ridesharing, core ridesharing losses improving, ongoing leverage in insurance costs, and the "high-growth, high-margin" revenue opportunities in Lyft Business, Anmuth tells investors in a research note. Further and importantly, on its earnings call last night, Uber (UBER) echoed Lyft's comments on the more favorable operating environment in the U.S., adds the analyst. He keeps an Overweight rating on Lyft with an $86 price target, suggesting 50% potential upside. The stock closed yesterday down $1.43 to $54.83.
05/31/19
ATLE
05/31/19
UPGRADE
ATLE
Overweight
Uber upgraded to Overweight from Neutral at Atlantic Equities
BYND Beyond Meat
$98.28

1.15 (1.18%)

05/28/19
JEFF
05/28/19
INITIATION
Target $85
JEFF
Hold
Jefferies puts Hold rating on Beyond Meat with expectations 'very high'
Jefferies analyst Kevin Grundy initiated coverage of Beyond Meat with a Hold rating and $85 price target. The company's "strong" leadership and growing brand equity, along with favorable secular tailwinds for plant-based proteins within a $1.4 trillion global meat industry, positions the company well for "rapid and sustainable growth," Grundy tells investors in a research note. However, the analyst believes expectations for Beyond Meat are already "very high." As such, bull case developments are likely needed to support the stock at current levels, says Grundy.
05/28/19
05/28/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. MasTec (MTZ) initiated with a Buy at UBS. 2. Beyond Meat (BYND) was initiated with an Overweight at JPMorgan, a Market Perform at William Blair, a Neutral at Credit Suisse, Goldman Sachs, and BofA/Merrill, and a Hold at Jefferies. 3. SciPlay (SCPL) was initiated with an Overweight at JPMorgan, an Outperform at Wedbush and RBC Capital, a Buy at BofA/Merrill, Goldman Sachs, Stifel, and Deutsche Bank, as well as an Equal Weight at Morgan Stanley. 4. JetBlue (JBLU) initiated with a Positive at Susquehanna. 5. Red River Bancshares (RRBI) initiated with an Equal Weight at Stephens. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/28/19
WBLR
05/28/19
INITIATION
WBLR
Market Perform
William Blair starts Beyond Meat at Market Perform despite bullish outlook
William Blair analyst Jon Andersen initiated coverage of Beyond Meat with a Market Perform rating. While the analyst is "quite bullish" on the plant-based food industry, he acknowledges that an investment in a high-growth company with a premium valuation "leaves less margin for error." Given that the stock price has nearly quadrupled from the initial public offering in early May, further stock price appreciation may be limited in the near term, Andersen tells investors in a research note.
05/28/19
WBLR
05/28/19
INITIATION
WBLR
Market Perform
Beyond Meat initiated with a Market Perform at William Blair
William Blair analyst Jon Andersen started Beyond Meat with a Market Perform rating.
DKS Dick's Sporting
$34.22

0.565 (1.68%)

05/29/19
BOFA
05/29/19
NO CHANGE
BOFA
Canada Goose may report Q3 upside, says BofA/Merrill
BofA/Merrill analyst Robert Ohmes recommends that investors buy Canada Goose (GOOS) ahead of its Q3 earnings today as part of his broader research note on athletic apparel. The analyst believes that the company could generate "higher than expected revenue growth" thanks to its Direct-To-Consumer channel after its expanded manufacturing capacity. Ohmes further notes that Canada Goose's company owned store count has risen to 11 from 5 last year, and longer term, could exceed revenue forecasts given its "early stage growth in China" and expansion into new categories like footwear. As part of the same research note, the analyst is also cautious on Dick's Sporting (DKS), forecasting its comps to fall by 1% in Q1 because of unfavorable spring weather conditions, challenging comparison in baseball on lapping changes in Little League rules, and licensing headwind from Eagles SuperBowl victory last year which boosted sales. Ohmes expects Dick's Sporting to return to positive same-store sales in Q2 on reduced headwinds in hunt category and improved allocation from footwear firms like Nike (NKE).
05/29/19
BARD
05/29/19
NO CHANGE
Target $36
BARD
Neutral
Dick's Sporting making progress on sales, margins, says Baird
Baird analyst Peter Benedict reiterates a Neutral rating and a $36 price target on Dick's Sporting, but acknowledges that the risk/reward is improving. The analyst notes that Q1 EPS beat expectations on stronger sales/gross margin, and prospects for continued sequential improvement "appear good." While Benedict believes some top-line conservatism appears at play, he sees tariffs remaining "a wildcard."
05/30/19
DBAB
05/30/19
NO CHANGE
Target $42
DBAB
Buy
Dick's Sporting sold off on tariff commentary on call, says Deutsche Bank
Deutsche Bank analyst Mike Baker attributes the post-earnings weakness yesterday in shares of Dick's Sporting Goods to commentary on the earnings call that management has not contemplated the recent increase from 10% to 25% tariffs in their updated guidance. However, this is "somewhat misleading" as the company did implicitly lower its earnings outlook by 4c, when adjusting out the impact of the increased share repurchase, Baker tells investors in a research note. He thinks Dick's updated guidance "embeds a level of conservatism simply due to the tariff uncertainty." The analyst lowered his price target for the shares to $42 from $45 and keeps a Buy rating on Dick's Sporting.
04/10/19
SBSH
04/10/19
INITIATION
Target $40
SBSH
Neutral
Dick's Sporting assumed with a Neutral at Citi
Citi analyst Paul Lejuez assumed coverage of Dick's Sporting Goods from Kate McShane and kept a Neutral rating on the shares. He raised his price target for the stock to $40 from $38. Dick's is facing declining traffic trends as more business moves online, which will likely continue to pressure EBIT margins, Lejuez tells investors in a research note.
HTZ Hertz
$14.57

-0.62 (-4.08%)

03/01/19
LEHM
03/01/19
UPGRADE
Target $18
LEHM
Equal Weight
Hertz upgraded to Equal Weight from Underweight at Barclays
Barclays analyst Brian Johnson upgraded Hertz Global Holdings to Equal Weight and raised his price target for the shares to $18 from $14. Strength in used car and rental car prices creates a favorable backdrop for Hertz to refinance its corporate debt, Johnson tells investors in a research note.
03/04/19
03/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Foot Locker (FL) upgraded to Buy from Hold at Pivotal Research with analyst Mitch Kummetz saying the company on Friday reported much better than expected Q4 results, and its fiscal 2019 same-store-sales and earnings growth outlook was also well above consensus. 2. Hasbro (HAS) upgraded to Market Perform from Underperform at BMO Capital with analyst Gerrick Johnson saying the stock's multiple will expand as "major theatrical events" approach later in the year. 3. Hertz (HTZ) upgraded to Buy from Neutral at Northcoast. 4. Extended Stay America (STAY) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling citing the company's Q4 earnings report. 5. Kraft Heinz (KHC) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Dara Mohsenian saying he believes FY19 estimates now look achievable following their recent correction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/04/19
NRCS
03/04/19
UPGRADE
NRCS
Buy
Hertz upgraded to Buy from Neutral at Northcoast
03/01/19
03/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hertz (HTZ) upgraded to Equal Weight from Underweight at Barclays with analyst Brian Johnson saying strength in used car and rental car prices creates a favorable backdrop for Hertz to refinance its corporate debt. 2. L Brands (LB) upgraded to Overweight from Equal Weight at Barclays with analyst Chethan Mallela saying the company's fiscal 2019 guidance should establish an earnings "floor," which creates an "increasingly positive" risk/reward for the shares. 3. Kraft Heinz (KHC) upgraded to Hold from Sell at Societe Generale. 4. Edison International (EIX) upgraded to Neutral from Underperform at BofA/Merrill with analyst Julien Dumoulin-Smith saying he sees progress by the California legislature to address utilities' current status of "insurer of last resort," potentially allowing a recovery in Edison shares. 5. Expedia (EXPE) upgraded to Buy from Hold at Argus with analyst John Staszak citing the company's "strong" Q4 results, anticipated 10%-15% adjusted EBITDA growth in 2019, the management's optimism about continued international expansion, and its attractive valuation at 17.9-times his expected forward earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
OAS Oasis Petroleum
$5.20

-0.04 (-0.76%)

01/09/19
PIPR
01/09/19
DOWNGRADE
Target $9
PIPR
Neutral
Oasis Petroleum downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Kashy Harrison downgraded Oasis Petroleum to Neutral and lowered his price target for the shares to $9 from $18.
04/23/19
IFSG
04/23/19
DOWNGRADE
IFSG
Market Perform
Oasis Petroleum downgraded to Market Perform from Outperform at IFS Securities
03/20/19
SOCO
03/20/19
UPGRADE
SOCO
Equalweight
Oasis Petroleum upgraded to Equalweight from Underweight at Capital One
Capital One upgraded Oasis Petroleum to Equal Weight citing the recent decision to slash activity and CAPEX, leaving the company in a better positioned for the current oil price environment.
01/23/19
SBSH
01/23/19
DOWNGRADE
Target $7
SBSH
Neutral
Oasis Petroleum downgraded to Neutral from Buy at Citi
Citi analyst Brian Downey downgraded Oasis Petroleum to Neutral and lowered his price target for the shares to $7 from $10 after taking over coverage from Robert Morris. The analyst believes a debate is forming around the optimal balance between free cash flow and growth for 2020 and beyond for the smid cap Exploration & Production companies. He likes the Permian Basin due to the region's "inventory quality and multiple positive developments in 2019" but also finds opportunities elsewhere.
CLVS Clovis
$15.01

-0.85 (-5.36%)

04/14/19
PIPR
04/14/19
NO CHANGE
Target $21
PIPR
Neutral
Clovis price target lowered to $21 on ATLAS trial at Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro lowered his price target for Clovis to $21 from $23 after the company announced that it was discontinuing the Phase II ATLAS trial of rucaparib in urothelial bladder cancer due to lack of efficacy. The analyst notes that this outcome is "not totally surprising" to him given the limited efficacy observed thus far for PARP inhibitors in the therapeutic setting outside of BRCA+. Catanzaro reiterates a Neutral rating on the shares.
04/15/19
HCWC
04/15/19
NO CHANGE
Target $37
HCWC
Buy
Clovis price target lowered to $37 from $39 at H.C. Wainwright
H.C. Wainwright analyst Edward White lowered his price target for Clovis Oncology to $37 from $39 after the company disclosed that the trial evaluating Rubraca as a monotherapy in patients with recurrent metastatic bladder cancer has been discontinued. The analyst notes that he only had given Rubraca in metastatic bladder cancer a 15% probability of success. He keeps a Buy rating on Clovis shares.
04/15/19
RHCO
04/15/19
NO CHANGE
Target $28
RHCO
Buy
Clovis price target lowered to $28 from $35 at SunTrust
SunTrust analyst Peter Lawson lowered his price target on Clovis to $28 after the company announced that it was discontinuing Phase 2 ATLAS trial of monotherapy PARP inhibitor rucaparib in urothelial bladder cancer. The analyst notes that he has removed the bladder cancer from his model but sees upside in the stock coming from the company's ovarian cancer program and following the 10%-15% decline in price. Lawson also keeps his Buy rating on Clovis shares.
05/29/19
GSCO
05/29/19
DOWNGRADE
Target $15
GSCO
Sell
Clovis downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Paul Choi downgraded Clovis Oncology to Neutral from Sell after assuming coverage of the name. He lowered his price target for the shares to $15 from $17. The stock's valuation is full relative to Rubraca's intermediate-term outlook absent clinical differentiation that supports label expansion, Choi tells investors in a research note. The analyst believes current expectations are "inflated" relative to the size of the opportunity for Rubraca in prostate cancer. His sales estimates are on average 25% below consensus estimates.
ALLY Ally Financial
$29.19

-0.05 (-0.17%)

04/22/19
BMOC
04/22/19
NO CHANGE
Target $39
BMOC
Market Perform
Ally Financial price target raised to $39 from $34 at BMO Capital
BMO Capital analyst James Fotheringham raised his price target on Ally Financial to $39 after its Q1 earnings beat. The analyst is keeping his Market Perform rating however, saying he is concerned about the company's capital, with 9.3% B3CET1 ratio as the "lowest among its cohort". The analyst add that he prefers other opportunities among his coverage of large-cap banks, specialty lenders, and financial technology stocks.
02/26/19
02/26/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exact Sciences (EXAS) upgraded to Buy from Neutral at Goldman Sachs by analyst Patrick Donnelly, who said the current momentum of the Cologuard commercial ramp provides "strong basis" for the company's premium valuation while the combination of positive Cologuard catalysts and new product roll-outs provide upside to current levels, even after the stock's 75% rally since the beginning of 2018. Exact Sciences is a "must-own growth stock" given the "clean runway forward that is largely in its control with potential for discovery value in the pipeline outside of Cologuard," the analyst said. 2. Siemens (SIEGY) upgraded to Overweight from Neutral at JPMorgan by analyst Andreas Willi, who sees a relative valuation opportunity after the stock's 27% underperformance over the past two years. He believes investor sentiment can improve "after a period where the story has drifted." 3. Kadmon (KDMN) upgraded to Buy from Neutral at Citi by analyst Robyn Karnauskas, who assigned a 50% probability to KD-025 in chronic graft versus host disease with an unadjusted ~$900M market opportunity. However, upside to the stock will depend on quality of the data likely, Karnauskas said. 4. EverQuote (EVER) upgraded to Buy following Q4 beat at BofA/Merrill by analyst Mat Schindler, who said user growth has re-accelerated, supporting evidence of a turnaround, and thinks estimates are conservative and views the risk/reward as attractive. 5. Ally Financial (ALLY) upgraded to Buy from Hold at Sandler O'Neill by analyst Christopher Donat, who said he believes Ally's near-prime auto finance book is "meaningfully less risky" than Santander Consumer's (SC) book or the unsecured credit cards of Discover (DFS) and Capital One (COF), yet all four stocks trade at similar multiples. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/02/19
SBSH
04/02/19
NO CHANGE
SBSH
Buy
Ally Financial buyback plan above forecast, says Citi
Citi analyst Arren Cyganovich says Ally Financial's new repurchase plan of up to $1.25B is above his forecast of $900M. The analyst is "somewhat surprised" by the 25% increase in the authorization with the implementation of the current expected credit loss model beginning on January 1, 2020, but he sees it as a sign of confidence that the company "can withstand the initial phased-in capital hit to book value." Cyganovich has a Buy rating on Ally Financial.
04/02/19
MSCO
04/02/19
NO CHANGE
Target $30
MSCO
Equal Weight
Ally buyback approval significantly higher than estimated, says Morgan Stanley
Morgan Stanley analyst Betsy Graseck noted that Fed CCAR instructions released on February 5 exempted banks with assets between $100B-$250B from the 2019 stress test, which meant that Ally Financial did not need to wait for Fed approval in June to announced that its board authorized the repurchase of up to $1.25B in common stock for 3Q19-2Q20. This $1.25B authorization is significantly higher than her $560M estimate, said Graseck, who raised her 2020 EPS estimate for Ally by 14c, or 3.5%, in response to the news. Graseck keeps an Equal Weight rating on Ally shares.

TODAY'S FREE FLY STORIES

WSC

WillScot

$14.18

-0.17 (-1.18%)

21:53
06/25/19
06/25
21:53
06/25/19
21:53
Initiation
WillScot initiated  »

WillScot initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYRN

Cyren

$1.60

(0.00%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
Cyren initiated at B. Riley FBR »

Cyren initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEC

Vectrus

$38.28

-0.12 (-0.31%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
Vectrus initiated at B. Riley FBR »

Vectrus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSPN

OneSpan

$13.81

-0.38 (-2.68%)

21:32
06/25/19
06/25
21:32
06/25/19
21:32
Initiation
OneSpan initiated at B. Riley FBR »

OneSpan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMBM

Cambium Networks

$0.00

(0.00%)

21:29
06/25/19
06/25
21:29
06/25/19
21:29
Syndicate
Cambium Networks 5.8M share IPO price $12.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

VICI

VICI Properties

$21.80

-0.52 (-2.33%)

21:27
06/25/19
06/25
21:27
06/25/19
21:27
Syndicate
VICI Properties 100M share Secondary priced at $21.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

20:25
06/25/19
06/25
20:25
06/25/19
20:25
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

GIS

General Mills

$53.70

0.04 (0.07%)

, PAYX

Paychex

$84.76

-1.41 (-1.64%)

20:25
06/25/19
06/25
20:25
06/25/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$53.70

0.04 (0.07%)

PAYX

Paychex

$84.76

-1.41 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

BAX

Baxter

$81.71

-0.58 (-0.70%)

19:32
06/25/19
06/25
19:32
06/25/19
19:32
Initiation
Baxter initiated at KeyBanc »

Baxter initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 16

    Sep

FB

Facebook

$188.87

-3.69 (-1.92%)

19:21
06/25/19
06/25
19:21
06/25/19
19:21
Periodicals
Brazil court reduces fine for Facebook's refusal to share data, Reuters says »

A Brazilian federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

PCG

PG&E

$21.62

-0.02 (-0.09%)

19:01
06/25/19
06/25
19:01
06/25/19
19:01
Periodicals
PG&E bondholders seek control of utility's bankruptcy, SVBJ reports »

PG&E's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$20.58

-0.58 (-2.74%)

18:55
06/25/19
06/25
18:55
06/25/19
18:55
Hot Stocks
Kinder Morgan says 'very pleased' with Travis County District Court ruling »

Kinder Morgan issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.71

-0.47 (-1.42%)

, FDX

FedEx

$156.00

-4.88 (-3.03%)

18:37
06/25/19
06/25
18:37
06/25/19
18:37
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Micron…

MU

Micron

$32.71

-0.47 (-1.42%)

FDX

FedEx

$156.00

-4.88 (-3.03%)

AVAV

AeroVironment

$61.41

-0.52 (-0.84%)

GBT

Global Blood Therapeutics

$62.42

-0.87 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

  • 26

    Jun

18:15
06/25/19
06/25
18:15
06/25/19
18:15
General news
Breaking General news story  »

St. Louis Federal Reserve…

CMCSA

Comcast

$42.75

-0.85 (-1.95%)

, CMCSK

Comcast

$0.00

(0.00%)

18:06
06/25/19
06/25
18:06
06/25/19
18:06
Periodicals
NBC to pull 'The Office' from Netflix in 2021, CNBC says »

Comcast's (CMCSA)…

CMCSA

Comcast

$42.75

-0.85 (-1.95%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$360.29

-10.72 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 17

    Jul

  • 25

    Jul

FDX

FedEx

$156.00

-4.88 (-3.03%)

18:03
06/25/19
06/25
18:03
06/25/19
18:03
Hot Stocks
FedEx says U.S. government placing burden on carriers with regulations »

Says lawsuit over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

18:01
06/25/19
06/25
18:01
06/25/19
18:01
Hot Stocks
FedEx says Huawei packages 'only peripherally' involved in U.S. lawsuit »

Says there's been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

QD

Qudian

$8.46

-0.275 (-3.15%)

18:00
06/25/19
06/25
18:00
06/25/19
18:00
Syndicate
Breaking Syndicate news story on Qudian »

Qudian files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDX

FedEx

$156.00

-4.88 (-3.03%)

, AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

17:57
06/25/19
06/25
17:57
06/25/19
17:57
Hot Stocks
Breaking Hot Stocks news story on FedEx, Amazon.com »

FedEx says loss of Amazon…

FDX

FedEx

$156.00

-4.88 (-3.03%)

AMZN

Amazon.com

$1,879.26

-34.17 (-1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:56
06/25/19
06/25
17:56
06/25/19
17:56
Hot Stocks
FedEx sees buyback level significantly lower in FY20 »

Says has created new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:51
06/25/19
06/25
17:51
06/25/19
17:51
Hot Stocks
FedEx says has made no pricing changes »

Says business realignment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:46
06/25/19
06/25
17:46
06/25/19
17:46
Hot Stocks
FedEx says international commercial team still poised for growth »

Says TNT Express…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:43
06/25/19
06/25
17:43
06/25/19
17:43
Hot Stocks
FedEx says global trade picture 'less than ideal' »

Says "all-in"…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:38
06/25/19
06/25
17:38
06/25/19
17:38
Hot Stocks
FedEx calls FY20 a 'transition year' »

Says FY20 a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

FDX

FedEx

$156.00

-4.88 (-3.03%)

17:37
06/25/19
06/25
17:37
06/25/19
17:37
Hot Stocks
FedEx says intends to substantially grow e-commerce business »

Sees FedEx Freight will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.